Meet Us Online at The 3rd International Electronic Conference on Diversity (IECD 2024), 15–17 October 2024
We are pleased to announce that The 3rd International Electronic Conference on Diversity (IECD 2024) is back. The conference is organized by the MDPI journal Diversity (ISSN: 1424-2818, Impact Factor: 2.4) and will take place virtually from 15 to 17 October 2024, Central European Summer Time.
IECD 2024 invites researchers from academia, as well as diversity practitioners, to contribute original findings, novel ideas, scientific concepts, new technologies and experiences to address diversity in various fields. The conference will focus on fostering discussions related to animal and plant diversity, with a special emphasis on conservation. We encourage submissions that refer to the following topics:
- Animal diversity;
- Biodiversity conservation;
- Marine diversity;
- Microbial diversity and culture collections;
- Phylogeny and evolution;
- Plant diversity.
Important Dates:
Deadline for abstract submission: 15 June 2024
Abstract acceptance notification: 15 July 2024
Registration deadline: 10 October 2024
Guide for Authors:
To submit your abstract, please click on the following link: https://sciforum.net/user/submission/create/1067.
To register for the event, please click on the following link: https://iecd2024.sciforum.net/#registration.
Note: We accept abstracts only for this conference. To publish a conference proceedings paper for free and submit a full manuscript to Diversity, please refer to the “Publication Opportunities” part in the “Instructions for Authors” section.
Best Oral Presentation Award and Best Poster Award:
There will be four winners selected for these awards. The winners will each receive an award of CHF 200, along with an offer to publish an extended paper, free of charge, in the Special Issue of Diversity.
For any enquiries regarding the event, please contact iecd2024@mdpi.com.
We look forward to seeing you at the 3rd International Electronic Conference on Diversity.
Conference Chair:
Prof. Dr. Michael Wink, Institute of Pharmacy and Molecular Biotechnology, Heidelberg University, Heidelberg, Germany